Presbia (NSDQ:LENS) touted interim data today from its U.S. pivotal clinical trial, which it hopes will eventually support pre-market approval from the FDA for its Flexivue Microlens. The company is 2 years into the 3-year long trial and said that it anticipates submitting final data to the FDA in September 2017. The company’s lens is intended to […]
Presbia
Presbia closes $2m Neoptics buy
Presbia (NSDQ:LENS) said today its Irish subsidiary closed its approximately $1.5 million acquisition of unspecified assets from Neoptics AG which included its intellectual property portfolio. The purchase includes Neoptics current and pending patents, trademarks, equipment, inventory, technical and other related documents, Presbia said. Hünenberg, Switzerland-based Neoptics makes the Icolens device, a lens designed to be implanted into the cornea […]
Presbia acquires Neoptics assets for $2m
Presbia (NSDQ:LENS) said yesterday that its Irish subsidiary agreed to pay about $1.5 million to acquire some unspecified assets from Neoptics AG. The CHF 1.5 million buyout includes Neoptics current and pending patents, trademarks, equipment, inventory, technical and other related documents, Presbia said. Hünenberg, Switzerland-based Neoptics makes the Icolens device, a lens designed to be implanted into […]
ResMed shuffles the deck at Brightree; taps Mellott as new CEO | Personnel Moves June 21, 2016
ResMed shuffles the deck at Brightree; taps Mellott as new CEO ResMed (NYSE:RMD) yesterday announced a mix-up at its Brightree business, tapping home medical equipment industry vet Matt Mellott as its new CEO and Bobby Ghoshal as its new COO. Former Brightree CEO and prez Dave Cormack will transition into a multi-year advisory role, the company […]
Presbia touts 6-month data for Flexivue microlens
Presbia (NSDQ:LENS) today reported interim data from a U.S. pivotal trial of its Flexivue microlens, touting an average gain of 5 lines of uncorrected near visual acuity and 99% maintenance of binocular uncorrected distance vision. The company reports a total of 421 subjects have been implanted with the Flexivue microlens in the trial, which is […]
J-Pac names new CFO, ops VP | Personnel Moves
J-Pac Medical said it named former GI Supply finance chief Michael Dolge to be its new CFO and tapped Phil Littlefield, a medtech veteran, to be its vice president of operations. Somersworth, N.H.-based J-Pac, which makes implantable textiles and offers packaging and manufacturing services to the medical device industry, said Dolge’s resume includes stints at […]
Presbia pivotal Microlens trial nears end
Presbia (NSDQ:LENS) said Monday it is nearing completion of enrollment in a pivotal trial of its Flexivue Microlens implant designed to treat presbyopia and is on track to submit its final pre market approval module. The Dublin-based company said it has enrolled 300 patients, and submission of its final PMA module will come after the 24-month […]
Cook elevates medical prez Yonkin to Cook Group prez | Personnel Moves
Cook said yesterday that Cook Medical president Pete Yonkman will become the new president of Cook Group Inc., as current president Kem Hawkins is slated to retire on July 1. “Under Kem’s leadership, we have seen exciting new opportunities to help patients, our employees, and the communities where we operate. With his guidance, our company […]
TAVI: Direct Flow taps ex-CoreValve chief Lemaitre | Personnel Moves
ConvaTec makes interim chief Moraviec CEO | Personnel Moves
ConvaTec, which is rumored to be exploring a sale, said yesterday that it made its interim CEO, former EMEA president Paul Moraviec, to be its new permanent CEO.
Luxembourg-based ConvaTec, which is owned by private equity firms Avista Capital Partners and Nordic Capital, tapped Moraviec to lead its business in Europe, the Middle East and Africa in 2009.